Trial Profile
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2013
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 03 Jun 2009 New trial record.